US voters support HIV/Aids relief – will Trump’s cuts backfire in the midterms?
Why this matters: a developing story that could shape the day's news cycle.
Global Pepfar program has long had Republican leadership and bipartisan support, but initiative is under fire US midterm voters overwhelmingly support Pepfar, an initiative to end HIV/Aids that also has strengthened health systems against other infectious disease threats but has come under fire from the Trump administration.About three in four (74%) of likely voters in the US midterm elections say they support funding the US President’s Emergency Plan for AIDS Relief (Pepfar), with voters more likely to back candidates who support Pepfar, according to a recent poll. Four in five (80%) of the voters said there is a moral argument for supporting lifesaving treatment for people at risk for or living with HIV/Aids, regardless of their personal choices. Continue reading...